Max Healthcare Institute Limited has issued an update regarding ongoing legal proceedings involving its subsidiary, Kalinga Hospital Ltd. (KHL). Further interlocutory petitions have been filed by the legal representatives of BRS Capital Two Pte. Limited before the Hon’ble National Company Law Tribunal (NCLT), Cuttack Bench, seeking interim reliefs. The matter was heard on September 8, 2026, with the NCLT directing respondents, including Max Healthcare, to file a reply within one week. The next hearing is scheduled for September 28, 2026.
Max Healthcare Provides Litigation Update
Max Healthcare Institute Limited has announced further developments concerning the legal petitions filed against its subsidiary, Kalinga Hospital Ltd. (KHL). These actions are being pursued by the legal representatives of BRS Capital Two Pte. Limited, who are the other shareholders of KHL from whom the Company acquired a majority equity stake.
NCLT Hearing and Interim Relief Sought
In addition to previous intimations, legal representatives of BRS Capital have filed further interlocutory petitions before the Hon’ble National Company Law Tribunal (NCLT), Cuttack Bench, seeking specific interim reliefs. The matter was heard on September 8, 2026. The NCLT has directed the respondents, which include Max Healthcare and its subsidiary, to file their reply, if any, within one week.
Next Steps and Timeline
The next date for the hearing of these petitions is scheduled for September 28, 2026. Max Healthcare confirmed that it received a copy of the order passed by the Hon’ble NCLT on September 10, 2026, at 4:42 pm IST. The company is providing this disclosure as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Source: BSE
